Market News AIOpen the app

Adagio Medical Holdings shared its Q3 2026 results, showing a profit of $17.8 million.

ResultsRead the original at SEC EDGAR
Neutral

ADGM reported $17.8 million in profit, mainly from a $23.0 million change in the reported value of its notes, and had no revenue. Clinical study progress and the board's search for options are positive steps, but the release reports no sales or patient results.

ADGM · Adagio Medical Holdings, Inc.

AI read · Neutral

The AI's read

The reported profit came mainly from a change in the reported value of the company's notes, not from device sales. ADGM had no revenue during the quarter because commercial activity in Europe was paused. At the same time, a new study began enrolling patients, and the board started exploring options to increase shareholder value. The release reports progress, but not patient results or a return to sales.

Get alerts for ADGM

Follow Adagio Medical Holdings, Inc. (ADGM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ADGM
Free on the App Store and Google Play, or on the web.